Ngā hua rapu - Deukchae Na

  • E whakaatu ana i te 1 - 4 hua o te 4
Whakamahine hua
  1. 1
    Genomic alterations in <i>BCL2L1</i> and <i>DLC1</i> contribute to drug sensitivity in gastric cancer

    Genomic alterations in <i>BCL2L1</i> and <i>DLC1</i> contribute to drug sensitivity in gastric cancer mā Hansoo Park, Sung‐Yup Cho, Hyerim Kim, Deukchae Na, Jee Yun Han, Jeesoo Chae, Chang‐Ho Park, Ok-Kyoung Park, Seoyeon Min, Jinjoo Kang, Boram Choi, Jimin Min, Jee Young Kwon, Yun‐Suhk Suh, Seong‐Ho Kong, Hyuk‐Joon Lee, Edison T. Liu, Jong‐Il Kim, Sung‐Hoon Kim, Han‐Kwang Yang, Charles Lee

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers

    Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers mā Sung‐Yup Cho, Yumi Oh, Eui Man Jeong, Sanghui Park, Dakeun Lee, Xiaorui Wang, Qiqi Zeng, Hongyu Qin, Fang Hu, Hui Gong, Xi Liu, Guanjun Zhang, Deukchae Na, Jieun Lee, Jeesoo Chae, Yun‐Suhk Suh, Seong‐Ho Kong, Hyukjoon Lee, Jong‐Il Kim, Hansoo Park, Chengsheng Zhang, Han-Kwang Yang, Charles Lee

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

    Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts mā Deukchae Na, Jeesoo Chae, Sung‐Yup Cho, Wonyoung Kang, Ahra Lee, Seoyeon Min, Jinjoo Kang, Min Jung Kim, Jaeyong Choi, Woochan Lee, Dongjin Shin, Ahrum Min, Yu-Jin Kim, Kyung-Hun Lee, Tae Yong Kim, Yun‐Suhk Suh, Seong‐Ho Kong, Hyukjoon Lee, Woo Ho Kim, Hansoo Park, Seock-Ah Im, Han-Kwang Yang, Charles Lee, Jong‐Il Kim

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients

    High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients mā Sung‐Yup Cho, Chang‐Ho Park, Deukchae Na, Jee Yun Han, Jieun Lee, Ok-Kyoung Park, Chengsheng Zhang, Chang Ohk Sung, Hyo Eun Moon, Yona Kim, Jeong Hoon Kim, Jong Jae Kim, Shin Kwang Khang, Do‐Hyun Nam, Jung Won Choi, Yeon‐Lim Suh, Dong Gyu Kim, Sung‐Hye Park, Hyewon Youn, Kyuson Yun, Jong‐Il Kim, Charles Lee, Sun Ha Paek, Hansoo Park

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: